TF and hepatocellular carcinoma: Similarly, in another study, anti-miR-221 was delivered to the human HCC cell line HepG2 using transferrin-modified NLCs, which demonstrated higher effectiveness in delivering anti-miR-221 to HepG2 cells through the transferrin-mediated endocytosis pathway compared to non-targeted NLCs.